01852nas a2200253   4500000000100000000000100001008004100002260005300043653002200096653000900118653002500127653001600152653002000168100001600188700001900204700001300223700001600236700001900252245009200271300001000363490000800373520120300381022001401584       2022                            d  c10/2022bSchlütersche Fachmedien GmbHaHannover10acanine parvovirus10aqPCR10aFeline panleukopenia10aCoronavirus10aGastroenteritis1 aA Citarová1 aJ Mojžišová1 aB Vojtek1 aL Zákutná1 aM Drážovská00aThe findings of FPV, CPV-2a, CPV-2b and FCoV in cats with signs of feline panleukopenia  a1–60 v1353 a<p>In the period from August 2019 to August 2020, a total of nine cases of feline panleukopenia (FPV) were detected in two interrelated animal shelter facilities located in the district of Brezno, central Slovakia. All symptomatic cats were tested for the presence of parvovirus in the faeces using a rapid test with all tests being positive. The described animals ranged in age from three months to four years. Post-mortem examinations were performed on six dead animals and samples were taken to determine the presence of feline panleukopenia (FPV), canine parvovirus (CPV) variants 2a and 2b and feline coronavirus (FCoV) in the faeces using the quantitative polymerase chain reaction (qPCR). The examination of the samples was carried out at the Idexx Laboratiories in Leipzig, Germany. Despite intensive therapy, eight cats died and only one survived. This represents a treatment success rate of 11,2%. The findings of the qPCR tests showed positive results for FPV, CPV variants 2a and 2b and for FCoV in the faeces.</p>

<p>These results suggest that co-infection with CPV-2 strains, FCoV and FPV in cats may significantly reduce the success rate of therapy for feline panleukopenia.</p>
  a1439-0299